#JAMA

Dena Grayson, MD, PhD

DrDenaGrayson

@MIT's Dr. Lydia Bourouiba warns: “pathogen-bearing droplets of ALL sizes can travel 23-27 feet.”She also warns: “droplets that settle along the trajectory can contaminate surfaces”—and “residues or droplet nuclei” may

GUYANN V 🇻🇦📿

Guyan941

One year ago today three churches and four Hotels were bombed in Sri Lanka on Easter Sunday by the terrorist group National Thowheeth Jama’ath who had pledged allegiance to ISIS.

Andrew Petrosoniak

petrosoniak

My take on TXA in TBI following an excellent review by @Kumait_Allawati @SameerSharifMD @Bram_Rochwerg & colleagues. disclosure I'm a co-author Study objective? What is the efficacy & safety of TXA

Maarten van Smeden

MaartenvSmeden

Interesting paper: a guide to reading machine learning articles in @JAMA_current: https://jamanetwork.com/journals/jama/article-abstract/2754798ICYI, have a couple of thoughts to share about this paper1/n TL;DR: overall, I think this article is a

Pradheep J. Shanker

Neoavatara

88% of COVID places on vents died; but put into context, 100% of them would have died if NOT placed on ventilation. So could look at it as a 12%

Seth Trueger

MDaware

one of the challenges communicating about COVID & public health is the risk is a *social* risk much more than an *individual* (risk for most people) for example, I see

James Sheppard

jamessheppard48

Less is more? Our new trial suggests #deprescribing #bloodpressure lowering medications is safe in the short-term in older people with frailty and multimorbidity – see thread for details https://jamanetwork.com/journals/jama/article-abstr

Infectious Diseases

InfectiousDz

So what's the big deal about taking unproven therapies?Well, with convalescent plasma, the most recent study https://www.medrxiv.org/content/10.1101/2020.08.12.20169359v1 showed 8.7% survived if given treatment in first 3 days, 11.9% su

HumAngle_

HumAngle_

JUST IN: Abubakar Shekau, in a new audio, has condemned the Kano State death sentence. According to the embattled #BokoHaram leader, there is no difference between the 'blasphemer' and those

David Fisman

DFisman

Just some back of the envelope math for y'all on TEST SENSITIVITY for PCR and covid "rule out". This is important when deciding whether or not PPE are needed for

BK Titanji #ILookLikeAScientist

Boghuma

Where we are with #tocilizumab for #COVID19 . Neat summary in @JAMA https://ja.ma/2IJ8HPc . The fact remains that we need good RCT data. The observational studies so far are small,

Ziad Obermeyer

oziadias

We know communities of color suffer most from COVID-19. The way we’re allocating $175b in relief funding is also biased against them.Thread on our new paper, led by superstar @pragyakakani

Joshua Weitz

joshuasweitz

Two critical sentences from a critical JAMA Currents article by Dr. David Hains and colleagues (including @florian_krammer):https://jamanetwork.com/journals/jama/article-abstract/2766215/a short thread on 'shield immunity' 1. The prevalence o

Allie Atkeson

aatkeson

THREAD: We must address the language around the racial disparities we are seeing in COVID19 deaths. These are not differences, coincidences or "because Black people have higher rates of certain

Karen

IDrawPicsAllDay

Ever wonder how the medical illustrators at @JAMA_current create figures like these? There’s a thread for that! Here it is!https://twitter.com/jama_current/status/1249880050763259905 Firstly, the process for this illustration was super sped up

Swapnil Hiremath, MD, MPH

hswapnil

Others may have made fun of this ridiculous foray from the @nytimes into guidelines But let’s quickly look at 2 related to the kidneys (H/t @edclark75 for pointing out this